{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:21:50Z","timestamp":1788517310689,"version":"build-2803163510"},"reference-count":56,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2016,6,14]],"date-time":"2016-06-14T00:00:00Z","timestamp":1465862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["CA129975"],"award-info":[{"award-number":["CA129975"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kentucky Lung Cancer Research Program","award":["GB150463"],"award-info":[{"award-number":["GB150463"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Oncolytic adenoviruses (Ads) have been shown to be safe and have great potential for the treatment of solid tumors. However, the therapeutic efficacy of Ads is antagonized by limited spread within solid tumors. To develop Ads with enhanced spread, viral particles of an E1-wildtype Ad5 dl309 was repeatedly treated with UV type C irradiation and selected for the efficient replication and release from cancer cells. After 72 cycles of treatment and cancer selection, AdUV was isolated. This vector has displayed many favorable characteristics for oncolytic therapy. AdUV was shown to lyse cancer cells more effectively than both E1-deleted and E1-wildtype Ads. This enhanced cancer cell lysis appeared to be related to increased AdUV replication in and release from infected cancer cells. AdUV-treated A549 cells displayed greater expression of the autophagy marker LC3-II during oncolysis and formed larger viral plaques upon cancer cell monolayers, indicating increased virus spread among cancer cells. This study indicates the potential of this approach of irradiation of entire viral particles for the development of oncolytic viruses with designated therapeutic properties.<\/jats:p>","DOI":"10.3390\/v8060167","type":"journal-article","created":{"date-parts":[[2016,6,14]],"date-time":"2016-06-14T11:12:12Z","timestamp":1465902732000},"page":"167","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Development of an Oncolytic Adenovirus with Enhanced Spread Ability through Repeated UV Irradiation and Cancer Selection"],"prefix":"10.3390","volume":"8","author":[{"given":"Stephen","family":"Wechman","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202, USA"},{"name":"Department of Surgery, University of Louisville School of Medicine, Louisville, KY 40202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Mei","family":"Rao","sequence":"additional","affiliation":[{"name":"James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3738-4138","authenticated-orcid":false,"given":"Pei-Hsin","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Surgery, St. Jude Children\u2019s Research Hospital, Memphis, TN 38105, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3610-260X","authenticated-orcid":false,"given":"Jorge","family":"Gomez-Gutierrez","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Louisville School of Medicine, Louisville, KY 40202, USA"},{"name":"James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"McMasters","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202, USA"},{"name":"Department of Surgery, University of Louisville School of Medicine, Louisville, KY 40202, USA"},{"name":"James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Louisville School of Medicine, Louisville, KY 40202, USA"},{"name":"James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40202, USA"},{"name":"Department of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, KY 40202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,6,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/sj.gt.3301398","article-title":"Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: A phase I trial","volume":"8","author":"Mulvihill","year":"2001","journal-title":"Gene Ther."},{"key":"ref_2","unstructured":"Berk, A.J. (2006). HowleyDMKP (ed) Fields Virology, Lippincott Williams & Wilkins."},{"key":"ref_3","first-page":"558","article-title":"Oncolytic viral therapy of malignant glioma","volume":"6","author":"Parker","year":"2009","journal-title":"Neurother. J. Am. Soc. Exp. NeuroTher."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00109-007-0291-1","article-title":"Cellular genetic tools to control oncolytic adenoviruses for virotherapy of cancer","volume":"86","author":"Nettelbeck","year":"2008","journal-title":"J. Mol. Med."},{"key":"ref_5","first-page":"189","article-title":"Advantages and disadvantages of multiple different methods of adenoviral vector construction","volume":"45","author":"Seth","year":"2000","journal-title":"Methods Mol. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"d1369","DOI":"10.2741\/A847","article-title":"Adenovirus and cell cycle control","volume":"7","author":"Kleinberger","year":"2002","journal-title":"Front. Biosci. J. Virtual Libr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0042-6822(87)90441-7","article-title":"Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection","volume":"156","author":"Barker","year":"1987","journal-title":"Virology"},{"key":"ref_8","first-page":"389","article-title":"Functions of the adenovirus E1B tumour antigens","volume":"5","author":"Stillman","year":"1986","journal-title":"Cancer Surv."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1101\/gad.7.4.535","article-title":"Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis","volume":"7","author":"Lowe","year":"1993","journal-title":"Genes Dev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/sj.cgt.7700923","article-title":"Selective replication of E1B55K-deleted adenoviruses depends on enhanced E1A expression in cancer cells","volume":"13","author":"Zheng","year":"2006","journal-title":"Cancer Gene Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.virol.2006.02.009","article-title":"Gene expression profiles of normal human lung cells affected by adenoviral E1B","volume":"350","author":"Rao","year":"2006","journal-title":"Virology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1128\/JVI.01708-07","article-title":"Adenovirus E1B55K region is required to enhance cyclin E expression for efficient viral DNA replication","volume":"82","author":"Zheng","year":"2008","journal-title":"J. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.3390\/v7112905","article-title":"Oncolytic Replication of E1b-Deleted Adenoviruses","volume":"7","author":"Cheng","year":"2015","journal-title":"Viruses"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Cheng, P.H., Rao, X.M., McMasters, K.M., and Zhou, H.S. (2013). Molecular basis for viral selective replication in cancer cells: Activation of CDK2 by adenovirus-induced cyclin E. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0057340"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00109-014-1214-6","article-title":"Virotherapy targeting cyclin E overexpression in tumors with adenovirus-enhanced cancer-selective promoter","volume":"93","author":"Cheng","year":"2015","journal-title":"J. Mol. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1186\/s12885-015-1731-x","article-title":"Oncolytic adenovirus targeting cyclin E overexpression repressed tumor growth in syngeneic immunocompetent mice","volume":"15","author":"Cheng","year":"2015","journal-title":"BMC Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1101\/gad.7.4.546","article-title":"Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B","volume":"7","author":"Debbas","year":"1993","journal-title":"Genes Dev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"7742","DOI":"10.1073\/pnas.89.16.7742","article-title":"The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins","volume":"89","author":"Rao","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","first-page":"2570","article-title":"The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha","volume":"12","author":"White","year":"1992","journal-title":"Mol. Cell. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.1128\/JVI.76.9.4547-4558.2002","article-title":"Bak and Bax function to limit adenovirus replication through apoptosis induction","volume":"76","author":"Cuconati","year":"2002","journal-title":"J. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.274.5286.373","article-title":"An adenovirus mutant that replicates selectively in p53-deficient human tumor cells","volume":"274","author":"Bischoff","year":"1996","journal-title":"Science"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1517\/14712598.1.3.525","article-title":"Oncolytic virotherapy for cancer with the adenovirus dl1520 (Onyx-015): Results of phase I and II trials","volume":"1","author":"Kirn","year":"2001","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sj.gt.3301377","article-title":"Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: What have we learned?","volume":"8","author":"Kirn","year":"2001","journal-title":"Gene Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/156800907780058817","article-title":"Clinical trials with oncolytic adenovirus in China","volume":"7","author":"Yu","year":"2007","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1158\/1078-0432.CCR-08-1161","article-title":"A novel A33 promoter-based conditionally replicative adenovirus suppresses tumor growth and eradicates hepatic metastases in human colon cancer models","volume":"15","author":"Cafferata","year":"2009","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/1743-422X-10-293","article-title":"Combination of autophagy inducer rapamycin and oncolytic adenovirus improves antitumor effect in cancer cells","volume":"10","author":"Cheng","year":"2013","journal-title":"Virol. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/35106065","article-title":"To cycle or not to cycle: A critical decision in cancer","volume":"1","author":"Malumbres","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/mt.2009.262","article-title":"A phase I study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumors","volume":"18","author":"Nemunaitis","year":"2010","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_29","first-page":"7464","article-title":"A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy","volume":"61","author":"DeWeese","year":"2001","journal-title":"Cancer Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/mt.2009.266","article-title":"Current issues and future directions of oncolytic adenoviruses","volume":"18","author":"Yamamoto","year":"2010","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.4161\/cbt.216","article-title":"Cancer-specific viruses and the development of ONYX-015","volume":"2","author":"McCormick","year":"2003","journal-title":"Cancer Biol. Ther."},{"key":"ref_32","first-page":"3073","article-title":"Adenovirus with insertion-mutated E1A selectively propagates in liver cancer cells and destroys tumors in vivo","volume":"63","author":"Zhao","year":"2003","journal-title":"Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic virotherapy","volume":"30","author":"Russell","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0092-8674(79)90275-7","article-title":"Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells","volume":"17","author":"Jones","year":"1979","journal-title":"Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/sj.cgt.7700739","article-title":"E1A-induced apoptosis does not prevent replication of adenoviruses with deletion of E1b in majority of infected cancer cells","volume":"11","author":"Rao","year":"2004","journal-title":"Cancer Gene Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1248\/bpb.19.1518","article-title":"A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet","volume":"19","author":"Ishiyama","year":"1996","journal-title":"Biol. Pharm. Bull."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.virol.2011.04.017","article-title":"Adenoviruses induce autophagy to promote virus replication and oncolysis","volume":"416","author":"Rao","year":"2011","journal-title":"Virology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.yjmcc.2015.03.001","article-title":"Too much or not enough of a good thing\u2014The Janus faces of autophagy in cardiac fuel and protein homeostasis","volume":"84","author":"Ren","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00403-012-1204-x","article-title":"Reduced expression of microtubule-associated protein 1 light chain 3 in hypertrophic scars","volume":"304","author":"Shi","year":"2012","journal-title":"Arch. Dermatol. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1093\/emboj\/19.21.5720","article-title":"LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing","volume":"19","author":"Kabeya","year":"2000","journal-title":"EMBO J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/path.2694","article-title":"Autophagy: Assays and artifacts","volume":"221","author":"Barth","year":"2010","journal-title":"J. Pathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/978-1-59745-561-9_35","article-title":"Phase I clinical trial of locoregional administration of the oncolytic adenovirus ONYX-015 in combination with mitomycin-C, doxorubicin, and cisplatin chemotherapy in patients with advanced sarcomas","volume":"542","author":"Opyrchal","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.3748\/wjg.v10.i24.3634","article-title":"Intra-tumor injection of H101, a recombinant adenovirus, in combination with chemotherapy in patients with advanced cancers: A pilot phase II clinical trial","volume":"10","author":"Lu","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"ref_44","first-page":"1307","article-title":"[Phase II clinical study of intratumoral H101, an E1B deleted adenovirus, in combination with chemotherapy in patients with cancer]","volume":"22","author":"Xu","year":"2003","journal-title":"Chin. J. Cancer"},{"key":"ref_45","first-page":"693","article-title":"Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies","volume":"9","author":"Makower","year":"2003","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nrc1750","article-title":"Recent progress in the battle between oncolytic viruses and tumours","volume":"5","author":"Parato","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1089\/hum.2010.227","article-title":"Strategies to enhance viral penetration of solid tumors","volume":"22","author":"Smith","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.gt.3302436","article-title":"Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas","volume":"12","author":"Galanis","year":"2005","journal-title":"Gene Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/gt.2012.13","article-title":"Isolation of more potent oncolytic paramyxovirus by bioselection","volume":"20","author":"Beier","year":"2013","journal-title":"Gene Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"8928","DOI":"10.1158\/0008-5472.CAN-08-1145","article-title":"Bioselection of a gain of function mutation that enhances adenovirus 5 release and improves its antitumoral potency","volume":"68","author":"Gros","year":"2008","journal-title":"Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1128\/JVI.77.4.2640-2650.2003","article-title":"Developing novel oncolytic adenoviruses through bioselection","volume":"77","author":"Yan","year":"2003","journal-title":"J. Virol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/35056522","article-title":"Molecular dissection of autophagy: Two ubiquitin-like systems","volume":"2","author":"Ohsumi","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1534-5807(04)00099-1","article-title":"Development by self-digestion: Molecular mechanisms and biological functions of autophagy","volume":"6","author":"Levine","year":"2004","journal-title":"Dev. Cell"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/mt.2010.22","article-title":"Verapamil enhances the antitumoral efficacy of oncolytic adenoviruses","volume":"18","author":"Gros","year":"2010","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"12243","DOI":"10.1128\/JVI.78.22.12243-12251.2004","article-title":"Conditionally replicating adenoviruses kill tumor cells via a basic apoptotic machinery-independent mechanism that resembles necrosis-like programmed cell death","volume":"78","author":"Abbas","year":"2004","journal-title":"J. Virol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1038\/sj.onc.1210977","article-title":"Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer","volume":"27","author":"Baird","year":"2008","journal-title":"Oncogene"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/8\/6\/167\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:25:25Z","timestamp":1760210725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/8\/6\/167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,14]]},"references-count":56,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6]]}},"alternative-id":["v8060167"],"URL":"https:\/\/doi.org\/10.3390\/v8060167","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,14]]}}}